Skip to main content
See every side of every news story
Published loading...Updated

Ionis Pharmaceuticals (NASDAQ:IONS) Director Joseph Wender Sells 11,200 Shares

Summary
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) Director Joseph Wender sold 11,200 shares of the business's stock in a transaction that occurred on Friday, October 31st. The stock was sold at an average price of $75.16, for a total value of $841,792.00. Following the completion of the sale, the director owned 64,035 shares of the company's stock, valued at $4,812,870.60. The trade was a 14.89% decrease in their position. The transact…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Wednesday, November 5, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal